Search Within

Andrew D Seidman

Formats
  1. Journal Article (175)
  2. Meeting Abstract (123)
  3. Conference Paper (9)
  4. Correspondence (3)
  5. Review (3)
  6. Book Section (2)
  7. Research Letter (2)
  8. Editorial (1)
Groups
  1. Breast Medicine Service (318)
  2. Department of Medicine (318)
  3. Solid Tumor Oncology Division (318)
  4. Survivorship Research (158)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (116)
  6. Epidemiology and Biostatistics (84)

More Groups

People
  1. Clifford Hudis (116)
  2. Larry Norton (99)
  3. Teresa Gilewski (38)
  4. Monica Fornier (37)
  5. Gabriella D'Andrea-Carlino (36)
  6. Violante Currie (32)

More People

Years
  1. 2025 (3)
  2. 2024 (4)
  3. 2023 (10)
  4. 2022 (6)
  5. 2021 (9)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (83)
  2. Breast Cancer Research and Treatment (25)
  3. Cancer Research (23)
  4. Clinical Breast Cancer (19)
  5. Seminars in Oncology (16)
  6. Oncology (Norwalk) (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (84)
  2. Elsevier Inc. (55)
  3. Springer (40)
  4. American Association for Cancer Research (36)
  5. Oxford University Press (29)
  6. C M P Medica LLC * The Oncology Group (14)

More Publishers

Results (318)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical trial of proton craniospinal irradiation for leptomeningeal metastases
    Journal Article

    Yang, T. J.; Wijetunga, N. A.; Yamada, J.; Wolden, S.; Mehallow, M.; Goldman, D. A.; Zhang, Z.; Young, R. J.; Kris, M. G.; Yu, H. A.; more...
    Neuro-Oncology (2021)

    Fulltext@MSK | Save
  • Comparative effectiveness research needs to consider optimal dosing and scheduling
    Correspondence

    Seidman, A. D.; de Stanchina, E.; Norton, L.; Morikawa, A.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Yoga for chemotherapy-induced peripheral neuropathy and fall risk: A randomized controlled trial
    Journal Article

    Bao, T.; Zhi, I.; Baser, R.; Hooper, M.; Chen, C.; Piulson, L.; Li, Q. S.; Galantino, M. L.; Blinder, V.; Robson, M.; more...
    JNCI Cancer Spectrum (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of proton craniospinal irradiation for patients with leptomeningeal carcinomatosis
    Meeting Abstract

    Wijetunga, N. A.; Mohammed, N.; Yamada, Y.; Wolden, S.; Seidman, A.; Yu, H.; Kris, M.; Malani, R.; Pentsova, E.; Boire, A.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer
    Journal Article

    Malani, R.; Fleisher, M.; Kumthekar, P.; Lin, X.; Omuro, A.; Groves, M. D.; Lin, N. U.; Melisko, M.; Lassman, A. B.; Jeyapalan, S.; more...
    Journal of Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel plus a reduced dose of capecitabine in patients with HER2-, HR+ metastatic breast cancer (MBC) who have not previously received a taxane
    Meeting Abstract

    Schwartzberg, L.; Asselah, J.; Bondarenko, I.; Chae, Y.; DaCosta, N.; Feng, Y. H.; Izarzugaza, Y.; Lemieux, J.; Liu, M. C.; Marx, G.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CONTESSA: A multinational, multicenter, randomized, phase 3 registration study of tesetaxel plus a reduced dose of capecitabine in patients with HER2-, hormone receptor + (HR+) metastatic breast cancer (MBC) who have previously received a taxane
    Meeting Abstract

    O'Shaughnessy, J.; Piccart, M.; Schwartzberg, L.; Cortes, J.; Harbeck, N.; Im, S. A.; Rugo, H.; Untch, M.; Yardley, D.; Bondarenko, I.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Initial real world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2- metastatic breast cancer
    Meeting Abstract

    Carter, G. C.; Sheffield, K. M.; Gossai, A.; Huang, Y. J.; Zhu, Y. E.; Bowman, L.; Smith, E. N.; Mathur, R.; Cohen, A. B.; Baxi, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative FLT-PET brain imaging study in patients receiving WBRT +/- sorafenib
    Meeting Abstract

    Morikawa, A.; Grkovski, M.; Patil, S.; Jhaveri, K.; Tang, K.; Humm, J.; Holodny, A.; Beal, K.; Schoder, H.; Seidman, A.
    Neuro-Oncology Advances (2019)

    Fulltext@MSK | Save
  • CONTESSA: A multinational, multicenter, randomized, phase III registration study of tesetaxel plus a reduced dose of capecitabine in patients (pts) with HER2-, hormone receptor plus (HR plus ) locally advanced or metastatic breast cancer (LA/MBC) who have previously received a taxane
    Meeting Abstract

    O'Shaughnessy, J.; Piccart, M.; Schwartzberg, L. S.; Cortes, J.; Harbeck, N.; Im, S. A.; Rugo, H. S.; Untch, M.; Yardley, D. A.; Bondarenko, I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save